U.S. Markets open in 2 hrs 52 mins
  • S&P Futures

    3,622.75
    -13.75 (-0.38%)
     
  • Dow Futures

    29,708.00
    -166.00 (-0.56%)
     
  • Nasdaq Futures

    12,260.50
    +3.00 (+0.02%)
     
  • Russell 2000 Futures

    1,840.60
    -12.40 (-0.67%)
     
  • Crude Oil

    44.96
    -0.57 (-1.25%)
     
  • Gold

    1,774.70
    -13.40 (-0.75%)
     
  • Silver

    22.32
    -0.32 (-1.43%)
     
  • EUR/USD

    1.1993
    +0.0023 (+0.1919%)
     
  • 10-Yr Bond

    0.8420
    0.0000 (0.00%)
     
  • Vix

    22.34
    +1.09 (+5.13%)
     
  • GBP/USD

    1.3354
    +0.0040 (+0.2978%)
     
  • USD/JPY

    103.9300
    -0.1550 (-0.1489%)
     
  • BTC-USD

    18,578.26
    +226.81 (+1.24%)
     
  • CMC Crypto 200

    366.45
    +28.95 (+8.58%)
     
  • FTSE 100

    6,371.28
    +3.70 (+0.06%)
     
  • Nikkei 225

    26,433.62
    -211.09 (-0.79%)
     

Tiziana Enters Human Trials for Covid-19 Treatment

Nov.02 -- Tiziana Life Sciences PLC is launching a clinical trial in Brazil involving humans where they will be treated with a nasally administered Foralumab, a monoclonal antibody. Gabriele Cerrone, the chief executive officer, speaks on "Bloomberg Markets."